Lupus and Rheumatoid Arthritis. Rhythm Venture Capital co-invests institutional seed to series A capital in companies taking transformational approaches to address significant unmet needs within digital health, healthcare services, biotech and life sciences.
Rhythm Venture Capital has launched Rhythm Fund X, a new fund. Rhythm Fund X has raised an undisclosed amount of funding in its first closing. The fund is seeking to make its initial investment by the end of the first quarter of 2019. Rhythm Venture Capital focuses on digital health, healthcare services, biotech and life sciences. PRESS RELEASE NEW YORK, Oct. 11, 2018 /PRNewswire/ — Today RHYTHM VENTURE CAPITAL announces the formation and first closing of its new venture capital fund. The new fund is called Rhythm Fund X and has formally accepted its first limited partners and aims to make its first investment by end of first quarter 2019. Rhythm Venture Capital is managed by partners Jordan S. Ryan and Jimmy D. Brown. The rest of the team being comprised of top tier experts in fields such as genomics and data driven solutions for diseases such as Cystic